|
|
Volumn 202, Issue 1-3, 2009, Pages 1-2
|
|
Special issue on cognitive enhancers
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATOMOXETINE;
BETA SECRETASE INHIBITOR;
CLOZAPINE;
DOPAMINE;
DOPAMINE 1 RECEPTOR;
GALANTAMINE;
GAMMA SECRETASE INHIBITOR;
GINKGO BILOBA EXTRACT;
METHYLPHENIDATE;
MODAFINIL;
N METHYL DEXTRO ASPARTIC ACID RECEPTOR;
NOOTROPIC AGENT;
NORADRENALIN;
PHOSPHODIESTERASE INHIBITOR;
PROTEIN KINASE INHIBITOR;
ALZHEIMER DISEASE;
ATTENTION DEFICIT DISORDER;
CLINICAL RESEARCH;
COGNITION;
COGNITIVE DEFECT;
DRUG RESEARCH;
EDITORIAL;
HUMAN;
LEARNING;
MEMORY;
MEMORY CONSOLIDATION;
NEUROPROTECTION;
NONHUMAN;
PRIORITY JOURNAL;
PSYCHOPHARMACOLOGY;
SCHIZOPHRENIA;
ANIMALS;
CATECHOLAMINES;
CENTRAL NERVOUS SYSTEM STIMULANTS;
COGNITION;
HUMANS;
LEARNING;
MEMORY;
NOOTROPIC AGENTS;
PSYCHOTROPIC DRUGS;
|
|
EID: 59449104063
PISSN: 00333158
EISSN: 14322072
Source Type: Journal
DOI: 10.1007/s00213-008-1389-z Document Type: Editorial |
|
Times cited : (5)
|
|
References (5)
|
